A Dual Focus for Schwab's International Dividend ETF This Week

Schwab International Dividend ETF (SCHY) announces its Q1 2026 dividend payment and annual index rebalancing. Key dates, yield, and portfolio impact explained.

Investors in the Schwab International Dividend Equity ETF (SCHY) have two key portfolio events converging this week. The fund is undergoing its annual index rebalancing, a process that reshapes its holdings, while simultaneously preparing to distribute its next quarterly dividend payment.

Upcoming Dividend Distribution Details

A fixed point on the calendar is the fund's approaching distribution. For shareholders looking to receive this payment, the critical dates and figures are as follows:

• Ex-Dividend Date: March 25, 2026
• Payable Date: March 30, 2026
• Estimated Distribution: $0.14 per share
• Indicated Dividend Yield: 4.02% (as of March 17)

To qualify for the upcoming distribution, investors must hold their positions before the ex-dividend date of March 25. The cash payment will then be issued on schedule by March 30.

Annual Index Rebalancing Underway

Concurrent with the dividend schedule, the ETF is implementing the results of its annual benchmark review. Each March, the fund's underlying index, the Dow Jones International Dividend 100 Index, is reconstituted. This rules-based review rigorously assesses all constituent companies for dividend quality and financial strength.

Firms that no longer meet the stringent criteria for consistency and low volatility are removed from the index. Consequently, the ETF manager executes targeted portfolio adjustments to realign the fund with its benchmark. This process is designed to maintain the quality of the 100 non-U.S. companies held within the portfolio.

The final implementation of these index changes will reveal which global blue-chip stocks are newly added or receive increased weightings in the coming days.

Strategy and Cost Profile

The ETF's methodology employs strict sector limits to avoid concentrated risks in industries such as financials or healthcare. Its global focus on established large-cap firms is illustrated by holdings like GSK, Roche, and BHP Group.

A fundamental advantage for long-term investor returns remains the fund's exceptionally low expense ratio. At just 0.08%, it ranks among the most cost-efficient vehicles available for accessing international dividend-paying equities.